Understanding genetic factors and misdiagnosis in cancer patients
Official title: Genetic predisposition and misdiagnosis of cancer in All of Us participants
Funded at Brigham Young University · NIH-10974720 · Data updated 2026-11-12
This study is looking at how our genes might sometimes lead to incorrect cancer diagnoses, and it's for people in the All of Us program who want to help improve cancer care by sharing their genetic information.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham Young University NIH-funded |
| Lab location | 1 site (Provo, United States) |
| Project start | July 15, 2024 |
| Project end | June 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $434,379 |
| NIH project number | 1R15CA293800-01 |
| Project ID | NIH-10974720 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals who have been diagnosed with cancer or are at high risk for developing cancer based on their genetic background.
✕Less likely to help
Patients who do not have a genetic predisposition to cancer or those who have already received definitive treatment may not benefit from this research.
What this research studies
This research investigates how genetic predispositions can lead to misdiagnosis of cancer among participants in the All of Us program. By analyzing large datasets and utilizing advanced bioinformatics, the study aims to identify common genetic markers that may influence cancer diagnosis and treatment outcomes. The approach includes examining the unique characteristics of tumors and their genetic profiles to improve diagnostic accuracy and patient care. Participants may contribute their genetic information to help develop better predictive models for cancer.
Why it matters
Potential benefit: If successful, this research could lead to more accurate cancer diagnoses and personalized treatment plans for patients.
How similar studies have gone: Previous research utilizing large genomic datasets has shown promise in improving cancer diagnosis and treatment, indicating that this approach could yield significant advancements.
Where this research is happening
-
Brigham Young University
Provo, United States Active
Researchers
- Principal investigator: Bailey, Matthew H — Brigham Young University
- Study coordinator: Bailey, Matthew H
Related research
Other NIH-funded projects on the same topics.
-
Genetic risk factors for heart attack in people with coronary artery disease
Researchers are studying how genes influence the risk of having a heart attack among people who already have coronary artery disease, with the goal of improving risk prediction and prevention.
-
Understanding Genetic Risks for Heart Attacks in People with Heart Disease
This project aims to discover the genetic factors that make some people with heart disease more likely to have a heart attack.
-
Investigating genetic factors linked to chronic lymphocytic leukemia (CLL)
This study is looking at how certain rare genetic changes, especially in the ATM gene, might make some people more likely to develop chronic lymphocytic leukemia (CLL), and it's inviting patients with known ATM gene changes to help us learn more about how these genetics relate to CLL and family cancer history.
-
Investigating how silica exposure and viral infections contribute to autoimmune diseases
This study is looking at how exposure to silica and viruses, along with genetic factors, might work together to trigger lupus, an autoimmune disease, and it’s using mice to see if these combined exposures lead to stronger immune responses than just one alone.
-
How genetics and medication affect cognitive impairment in people with HIV
This study is looking at how your genes might affect how well HIV treatment works for preventing memory and thinking problems, and it's for people living with HIV who want to understand more about their health.
-
Transition outcomes for adolescents and young adults with a cancer predisposition.
See if young adults with a genetic cancer predisposition establish and keep up care with adult providers and follow recommended cancer surveillance after they leave pediatric care at St. Jude.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.